We are live on ! Find out more
ALT icon

Altimmune
ALT

182 hedge funds and large institutions have $292M invested in Altimmune in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 65 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 23

48% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 44

43% more call options, than puts

Call options by funds: $23M | Put options by funds: $16.1M

20% more capital invested

Capital invested by funds: $243M → $292M (+$48.9M)

8% more funds holding

Funds holding: 169 → 182 (+13)

1.27% more ownership

Funds ownership: 55.64% → 56.91% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
182
Holders Change
+13
Holders Change %
+7.69%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
65
Reduced
44
Closed
23
Calls
$23M
Puts
$16.1M
Net Calls
+$6.89M
Net Calls Change
+$3.59M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$10.5M
2
BlackRock
BlackRock
New York
+$5.3M
3
UBS Group
UBS Group
Switzerland
+$3.34M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.89M
5
Millennium Management
Millennium Management
New York
+$1.84M

Top Sellers

Rank Fund Capital Flow
1
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$4.46M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.22M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.25M
4
Goldman Sachs
Goldman Sachs
New York
-$3.11M
5
Morgan Stanley
Morgan Stanley
New York
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$1.78M +$1.65M +215,375 +679%
N
27
Nuveen
North Carolina
$1.56M -$134K -17,504 -7%
Wells Fargo
28
Wells Fargo
California
$1.55M +$674K +88,209 +69%
Charles Schwab
29
Charles Schwab
California
$1.53M +$1.93K +253 +0.1%
HWAM
30
Hennion & Walsh Asset Management
New Jersey
$1.48M +$241K +31,482 +18%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$1.48M +$61.1K +8,001 +4%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$1.42M +$125K +16,387 +9%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.35M -$13.6K -1,777 -0.9%
Bank of America
34
Bank of America
North Carolina
$1.31M +$247K +32,382 +22%
Simplex Trading
35
Simplex Trading
Illinois
$1.31M +$367K +48,007 +36%
ETC
36
Exchange Traded Concepts
Oklahoma
$1.15M -$437K -57,188 -26%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$1.14M +$15K +1,964 +1%
Barclays
38
Barclays
United Kingdom
$1.14M +$13.7K +1,787 +1%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.01M – – –
Citigroup
40
Citigroup
New York
$899K +$557K +72,875 +141%
Focus Partners Wealth
41
Focus Partners Wealth
Massachusetts
$884K +$936K +122,539 New
MML Investors Services
42
MML Investors Services
Massachusetts
$789K +$572K +74,925 +217%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$756K -$33.2K -4,343 -4%
SAM
44
Silvercrest Asset Management
New York
$746K – – –
JP Morgan Chase
45
JP Morgan Chase
New York
$742K +$15.5K +2,028 +2%
Macquarie Group
46
Macquarie Group
Australia
$721K – – –
UBS AM
47
UBS AM
Illinois
$666K +$100K +13,126 +17%
SFWA
48
Summit Financial Wealth Advisors
Louisiana
$641K +$409K +53,570 +117%
VF
49
Virtu Financial
New York
$626K -$175K -22,928 -21%
Commonwealth Equity Services
50
Commonwealth Equity Services
Massachusetts
$621K -$23.1K -3,026 -3%
1
2
3 4 5

ALT Hedge Fund Activity: Q4 2024 in Review

182 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2024, worth a combined $292M — up 20% from $243M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ALT positions and 23 closed out — a net gain of 15 holders — while 65 added to existing stakes and 44 trimmed.

The largest buyer was Ameriprise, adding an estimated $10.5M. The largest seller was Capital Fund Management (CFM), exiting entirely with an estimated $4.46M sold.

  • 182 institutional investors held Altimmune (ALT) as of Q4 2024, up from 169 in Q3 2024.
  • Funds reported $292M of Altimmune stock for Q4 2024, up 20% quarter-over-quarter.
  • 38 funds opened new Altimmune positions in Q4 2024 and 23 closed out, a net change of +15 holders.
  • The largest Altimmune buyer in Q4 2024 was Ameriprise, an estimated $10.5M added.
  • The largest Altimmune seller in Q4 2024 was Capital Fund Management (CFM), an estimated $4.46M sold.

Based on aggregated 13F filings for Q4 2024.